NCT03218085View on ClinicalTrials.gov

Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions
HIV/AIDSMenopauseInflammation Vagina
Interventions
DRUG

Tenofovir

Two cervical biopsies, blood plasma, PBMC, and two cervicovaginal swabs will be collected at a single study visit

DRUG

Emtricitabine

Two cervical biopsies, blood plasma, PBMC, and two cervicovaginal swabs will be collected at a single study visit

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

American College of Clinical Pharmacy

OTHER

lead

University of Minnesota

OTHER

NCT03218085 - Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract | Biotech Hunter | Biotech Hunter